# Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside

> **NCT06324877** · NA · UNKNOWN · sponsor: **The University of Queensland** · enrollment: 10 (estimated)

## Conditions studied

- Ataxia Telangiectasia

## Interventions

- **DRUG:** Nicotinamide riboside

## Key facts

- **NCT ID:** NCT06324877
- **Lead sponsor:** The University of Queensland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-01
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06324877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06324877, "Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06324877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*